Literature DB >> 3202458

The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms.

I B Tager1, M R Segal, F E Speizer, S T Weiss.   

Abstract

Epidemiologic investigations into the natural history of airway obstructive disease have focused on both the growth and decline of lung function measurements. Although a general picture has emerged as to overall patterns of growth/decline, uncertainty remains with regard to important details of these patterns. Pulmonary function data from subjects aged 5 yr and and older who participated in any or all of the first 10 annual surveys of the East Boston population-based study have been used to investigate patterns of growth and decline of lung function derived from maximal forced expiratory maneuvers. At each annual survey, subjects completed a standardized respiratory illness and smoking questionnaire and provided forced expiratory volume-time curves from which forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) were derived. A nonparametric curve smoothing method was used to provide an overall summary of growth and decline of each measure of function. Asymptomatic, nonsmoking males demonstrated a pattern of growth of FEV1 that included a prolonged plateau phase or period of slow, continued growth from ages 23 to 35 yr. Decline in lung function began after this period and occurred in two phases that averaged about -20 and -30 ml/yr. In contrast, no plateau phase was observed for male current smokers. In these smokers, decline in FEV1 began in the early part of the third decade at a rate only slightly greater than that observed for nonsmokers (-25 to -30 ml/yr). Similar patterns and rates of decline were observed for females, although the presence of a plateau phase was less clearly discernible. These data suggest that a major effect of cigarette smoking on lung function decline involves the premature onset of a "normal" rate of decline in function and, to a lesser extent, more rapid rates of decline later in life and that the pattern and magnitude of decline is similar in males and females.

Entities:  

Mesh:

Year:  1988        PMID: 3202458     DOI: 10.1164/ajrccm/138.4.837

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  55 in total

1.  Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function.

Authors:  F D Gilliland; K Berhane; R McConnell; W J Gauderman; H Vora; E B Rappaport; E Avol; J M Peters
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study.

Authors:  M Pelkonen; I L Notkola; H Tukiainen; M Tervahauta; J Tuomilehto; A Nissinen
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

3.  Effects of the multiple risk factor intervention trial smoking cessation program on pulmonary function. A randomized controlled trial.

Authors:  W S Browner; A G Du Chene; S B Hulley
Journal:  West J Med       Date:  1992-11

4.  Genetic ancestry in lung-function predictions.

Authors:  Rajesh Kumar; Max A Seibold; Melinda C Aldrich; L Keoki Williams; Alex P Reiner; Laura Colangelo; Joshua Galanter; Christopher Gignoux; Donglei Hu; Saunak Sen; Shweta Choudhry; Edward L Peterson; Jose Rodriguez-Santana; William Rodriguez-Cintron; Michael A Nalls; Tennille S Leak; Ellen O'Meara; Bernd Meibohm; Stephen B Kritchevsky; Rongling Li; Tamara B Harris; Deborah A Nickerson; Myriam Fornage; Paul Enright; Elad Ziv; Lewis J Smith; Kiang Liu; Esteban González Burchard
Journal:  N Engl J Med       Date:  2010-07-07       Impact factor: 91.245

Review 5.  State of the Art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease.

Authors:  Eric A Hoffman; Brett A Simon; Geoffrey McLennan
Journal:  Proc Am Thorac Soc       Date:  2006-08

Review 6.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

7.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Anne L Wright; Stefano Guerra; Fernando D Martinez
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 8.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

9.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 10.  Natural history of emphysema.

Authors:  Omar A Minai; Joshua Benditt; Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.